Insmed Unveils BRINSUPRI as a First-Line NCFB Innovation
Non-cystic fibrosis bronchiectasis (NCFB) represents a persistent chronic respiratory ailment marked by sustained inflammatory processes, cyclical infectious complications, and continuous lung structural deterioration. Traditional therapeutic approaches predominantly target symptom relief rather than addressing fundamental disease pathways, resulting in significant treatment deficiencies...
0 Reacties
0 aandelen